Edurant

Edurant (Rilpivirine) is an antiretroviral medication used to manage HIV. This oral medication is part of combination therapy for HIV-1 infection in adults.

Edurant, containing the active ingredient Rilpivirine, is primarily used in the treatment of HIV-1 infection. It is typically prescribed as part of a combination therapy to help control the virus. Rilpivirine works by inhibiting the virus's ability to replicate, which can help reduce the amount of HIV in the body. This medication is not a cure for HIV but can help manage the condition when used as directed by a healthcare provider.

Common effects of Edurant may include headache, dizziness, nausea, and rash. Some individuals may also experience changes in body fat distribution. It is important to discuss any persistent or severe side effects with a healthcare provider.

Edurant should be handled with care and stored as directed. It is important to follow the prescribed dosage and not to share this medication with others. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Edurant may interact with certain medications, including antacids, proton pump inhibitors, and other antiretroviral drugs. It is important to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication while on Edurant.